Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
400
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
-39.3K
-
Total reported value, excl. options
-
$6.6B
-
Value change
-
-$18.3M
-
Put/Call ratio
-
1.96
-
Number of buys
-
202
-
Number of sells
-
-170
-
Price
-
$350.56
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2020
450 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q1 2020.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 400 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
.
Largest 10 shareholders include BlackRock Inc. (2.24M shares), VANGUARD GROUP INC (2.01M shares), FMR LLC (731K shares), STATE STREET CORP (687K shares), AMERICAN CENTURY COMPANIES INC (641K shares), WELLS FARGO & COMPANY/MN (508K shares), ATLANTA CAPITAL MANAGEMENT CO L L C (455K shares), WESTFIELD CAPITAL MANAGEMENT CO LP (390K shares), AQR CAPITAL MANAGEMENT LLC (386K shares), and ALLIANCEBERNSTEIN L.P. (384K shares).
This table shows the top 400 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.